powerful

A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

Well-chosen 1246 compounds with unique structures targeting nervous system;

A unique collection of 2703 natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 989 compounds without compro

A unique collection of 2910 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；

A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

A unique collection of 246 fragment-like small molecules for FBDD;

A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；

702 glycometabolism-related comounds, can be used for HTS and HCT;

48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

119 tumor-targeted drugs that can be used for high-throughput and high-content screening.

210 macrocyclic compounds of known activity for high-throughput, high-content screening;

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 1480 compounds from food as medicine for high throughput and high content screening;

A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A collection of 1279 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

1119 drug fragments，a must-have tool for FBDD;

A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；

678 hypertension-related small molecules for high-throughput and high-content screening.

Well-chosen 1468 anti-tumor compounds with unique structures;

A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;